NEW YORK: Scientists believe edaravone could help eliminate Alzheimer’s build up of amyloid plaques in the brain. In tests on mice, researchers said it was able to “prevent and treat” the disease by “rescuing the cognitive deficits”.
Edaravone is marketed in Japan to treat acute ischemic stroke patients presenting within 24 hours of attack though it is not licensed in Europe or the US for any condition.
A study’s initial findings suggest it “holds a promise as a therapeutic agent for Alzheimer’s” by targeting multiple key pathways of the disease…